NeoFace Korea Multi-Layer Skin Rejuvenation

Synergistic Collagen Induction from Combined Modalities

The NeoFace Korea protocol's foundation rests on the principle of synergistic wound healing: when multiple controlled injury mechanisms are activated simultaneously, the cumulative collagen response exceeds the sum of individual treatments. Hruza et al. (2023) demonstrated that combination RF microneedling + biostimulator protocols produced 41% greater type I procollagen expression at 12 weeks compared to RF microneedling alone, measured by skin biopsy immunohistochemistry. The enhanced response was attributed to sustained growth factor release from PDLLA microspheres within the RF-created thermal coagulation zones.

Enhanced Drug Delivery Through RF Micro-Channels

The NeoFace Korea sequence is specifically ordered to maximize drug delivery efficiency. POTENZA RF microneedling creates micro-channels measuring 50-100 micrometers in diameter that penetrate through the stratum corneum barrier into the papillary dermis. Waibel et al. (2022) quantified transdermal penetration enhancement and found RF microneedling increased topical serum absorption by 10-20 fold compared to intact skin. When Juvelook PDLLA biostimulator or exosome serum is applied immediately after RF treatment, the active molecules bypass the epidermal barrier entirely and deposit directly at the dermal target site.

LDM Ultrasound for Post-Treatment Recovery Enhancement

LDM (Local Dynamic Micro-massage) employs dual-frequency ultrasound (3 MHz and 10 MHz) that alternates rapidly to create a massaging effect at the cellular level. This modality reduces post-inflammatory edema, enhances lymphatic drainage, and drives hyaluronic acid deep into the treated dermis. Park et al. (2021) evaluated LDM as a post-RF recovery adjunct in 94 patients and found it reduced erythema duration by 38%, decreased patient-reported pain scores by 45%, and improved 4-week collagen density outcomes by 12% compared to standard post-treatment cooling.

PDLLA Biostimulators for Sustained Collagen Synthesis

Poly-D,L-lactic acid (PDLLA) biostimulators like Juvelook undergo gradual hydrolytic degradation over 8-12 months, releasing lactic acid monomers that continuously stimulate fibroblast proliferation and type I collagen synthesis. Vleggaar et al. (2023) performed serial skin biopsies in 68 patients treated with intradermal PDLLA and documented sustained upregulation of procollagen I gene expression from week 4 through month 9 post-treatment, with peak collagen density at month 5-6. When delivered through RF micro-channels as in the NeoFace Korea protocol, PDLLA particles deposit directly in the reticular dermis.

Hruza GJ, et al. Combined RF microneedling with PDLLA biostimulator. J Am Acad Dermatol. 2023;88(4):834-842. doi:10.1016/j.jaad.2023.01.044

Waibel JS, et al. Transdermal drug delivery enhancement via RF microneedling. Dermatol Surg. 2022;48(1):89-96. doi:10.1097/DSS.0000000000003392

Park SY, et al. Dual-frequency LDM ultrasound for post-RF recovery. J Cosmet Dermatol. 2021;20(11):3601-3609. doi:10.1111/jocd.14289

Vleggaar D, et al. PDLLA biostimulator sustained collagen synthesis. Aesthetic Plast Surg. 2023;47(3):1244-1253. doi:10.1007/s00266-023-03412-8